
CELLphenomics and Charles River Announce Agreement, Expanding 3D In Vitro Services for Cancer Therapy Drug Screening
CELLphenomics and Charles River Laboratories International, Inc. (NYSE: CRL) announced an agreement, that provides Charl…
CELLphenomics and Charles River Laboratories International, Inc. (NYSE: CRL) announced an agreement, that provides Charl…
Research collaboration leverages bit.bio’s machine learning-powered discovery platform to identify transcription factor…
- The HOPE (Hydrogen Offshore Production for Europe) project is being coordinated by Lhyfe (France) and implemented by e…
CELLphenomics and KYAN Therapeutics announced their new partnership today. By combining KYAN's technology platform, Opti…
Radioactivity can save lives. When neither chemotherapy or surgery nor radiation from the outside help against a tumor,…
Closing of seed round completed raising €3.7 million from SARSTEDT, High-Tech Gründerfonds (HTGF), R3 Consulting, ARVE C…
The International Federation of Societies of Cosmetic Chemists announced the winner at the closing ceremony of the 2021…
PMI and TissUse have signed a collaboration agreement to utilize PMI’s InHALES technology in combination with TissUse’s…
DOI:10.3791/61210 Hedwig M. Braakhuis1, Ruiwen He1,2, Rob J. Vandebriel1, Eric R. Gremmer1, Edwin Zwart1, Jolanda P. V…
faCellitate, a venture team of Chemovator GmbH, the internal business incubator of BASF, and a specialist in the develop…